Brillanz Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 529.78%
(FY 2022)
- Profit 45.15%
(FY 2022)
- Ebitda 54.80%
(FY 2022)
- Net Worth -15.35%
(FY 2022)
- Total Assets 184.76%
(FY 2022)
About Brillanz Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prannoti Mote and Deepali Tarate serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC290928
- Company No.
290928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2017
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Kamothe, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Brillanz Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prannoti Mote  | Director | 08-Feb-2017 | Current |
| Deepali Tarate | Director | 08-Feb-2017 | Current |
Financial Performance and Corporate Structure Insights of Brillanz Pharma.
Brillanz Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 529.78% increase. The company also saw a substantial improvement in profitability, with a 45.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brillanz Pharma?
In 2018, Brillanz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Brillanz Pharma?
Unlock and access historical data on people associated with Brillanz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brillanz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brillanz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
